Eaton Vance Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Eaton Vance Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-219	Closed	-$26K	–	3151
2021 Q1	$26K	Buy	+219	New	+$25.9K	﹤0.01%	1990

Eaton Vance Management's CBPO Position: Q2 2021 in Review

Eaton Vance Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 219 shares — an estimated $26K sold.

Eaton Vance Management first reported a position in CBPO in Q1 2021 and held it in 1 quarter. The position peaked at $26K in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Eaton Vance Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Eaton Vance Management sold 219 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $26K.
Eaton Vance Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2021 and held it in 1 quarter.
Eaton Vance Management's China Biologic Products Holdings, Inc. position peaked at $26K in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.